Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumors
Not Applicable
- Conditions
- Patients with bone metastases newly treated by zoledronic acid
- Registration Number
- JPRN-UMIN000018556
- Lead Sponsor
- agoya University Graduate School and School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
Fracture, No consent, Contraindication for zoledronic acid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic effects of CT and bone scintigraphy (3 and 6 months after treatments)
- Secondary Outcome Measures
Name Time Method Value and change of biomarkers, Pain score, Analgesic score, Side effect, PS